New Ovarian Cancer Findings Reported from Rudjer Boskovic Institute (Carboplatin-induced Upregulation of Pan β-tubulin and Class Iii β-tubulin Is Implicated In Acquired Resistance and Cross-resistance of Ovarian Cancer).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      CROATIA
    • Abstract:
      Keywords for this news article include: Zagreb, Croatia, Europe, Alkylating Agents, Antineoplastics, Cancer, Carboplatin Therapy, Drug Resistance, Drugs and Therapies, Gynecology, Health and Medicine, Microtubule Proteins, Nerve Tissue Proteins, Oncology, Organoplatinum Compounds, Ovarian Cancer, Pharmaceuticals, Tubulin, Women's Health, Rudjer Boskovic Institute. Keywords: Zagreb; Croatia; Europe; Alkylating Agents; Antineoplastics; Cancer; Carboplatin Therapy; Drug Resistance; Drugs and Therapies; Gynecology; Health and Medicine; Microtubule Proteins; Nerve Tissue Proteins; Oncology; Organoplatinum Compounds; Ovarian Cancer; Pharmaceuticals; Tubulin; Women's Health EN Zagreb Croatia Europe Alkylating Agents Antineoplastics Cancer Carboplatin Therapy Drug Resistance Drugs and Therapies Gynecology Health and Medicine Microtubule Proteins Nerve Tissue Proteins Oncology Organoplatinum Compounds Ovarian Cancer Pharmaceuticals Tubulin Women's Health 814 814 1 10/30/23 20231103 NES 231103 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on Oncology - Ovarian Cancer is the subject of a report. [Extracted from the article]
    • Abstract:
      Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)